dannce.ai is commercializing DANNCE, a behavioral quantification platform for tracking human movement and analyzing it for signatures of neurological disease. The technology was developed at Duke and Harvard, and the team is using their system to help drug developers better characterize the efficacy of neurological therapeutics and automating clinical assessments to democratize access to quality neurological care (you can think of them as building a digital neurologist).